Introduction
Divalent cations are required for the binding of some extracellular matrix proteins to their cell surface receptors. Some ofthe best known examples are the binding of fibronectin (FN)', vitronectin (VN), and fibrinogen to integrins, a group of cell adhesion receptors that recognize the Arg-Gly-Asp (RGD) sequence in ligand proteins (I1-3). In the absence of divalent cations or in the presence ofEDTA, a divalent cation chelator, the binding is dramatically diminished. Recently, it was reported that thrombospondin (TSP), a glycoprotein rich in platelet agranules and also secreted by many kinds of cultured cells, binds to U937 cells, a human monocyte tumor cell line, in a Ca2+-enhancible and EDTA-inhibitable manner (4, 5) . Binding is presumably via the membrane glycoprotein receptor GP IV (glycoprotein IV), since OKM5 monoclonal antibody against GP IV has an inhibitory effect on the binding similar to EDTA (5) . GP IV is also present on human platelets, monocytes, endothelial cells, and several tumor cell lines (6) (7) (8) . TSP interacts with purified GP IV in vitro, and the interaction can be inhibited by EDTA, but not by RGD peptide (9) . Studies by others have provided both supportive (10) and nonsupportive (1 1, 12) evidence for the hypothesis that GP IV is a receptor for TSP.
TSP is a heparin-binding protein, composed of three disulfide-bonded large (150-kD) identical subunits (for recent review, 13). A 25-kD heparin-binding domain, located at NH2-terminal ofthe molecule, has been isolated and characterized ( 14) . We have shown that cell surface heparan sulfate proteoglycan is a major mediator of the binding, endocytosis, and degradation of TSP by cells (15) (16) (17) (18) . The glycosaminoglycan chain of heparan sulfate proteoglycan interacts with the heparin-binding domain of TSP (18, 19) . Heparin, which binds to TSP with a higher affinity than does heparan sulfate proteoglycan, is a potent inhibitor of TSP binding to many kinds ofcells (15) (16) (17) (18) 20) .
It is intriguing that heparin enhances instead of inhibits the binding of TSP to U937 cells in the presence of 1 mM extra Ca2+ (4) . It prompted us to repeat this experiment in order to understand the mechanism. We reproduced the results by following the published methods. But our further studies showed that addition of extra Ca2+ to the assay medium (RPMI cell culture medium) resulted in an insoluble calcium precipitate, which is solubilized by EDTA. We report in this paper shown). The solution was visibly turbid. The turbidity could be removed either by centrifugation of the medium to yield a white precipitate, or by addition of EDTA to the medium. When extra Ca2+ was added to a different cell culture medium, MEM, turbidity increase was also observed. There was a greater turbidity increase in the media at pH 8.3 than at pH 7.4. For RPMI, however, there was a considerable turbidity increase even at pH 7.4 when 1 mM extra Ca2+ was added. At this pH, 2 mM extra Ca2+ did not increase turbidity in MEM. Addition of Mg2+, up to 10 mM, had no effect on light scattering in either medium (not shown). There was no turbidity increase in CF-HBSS when up to 6 mM Ca2+ was added.
The Ca2'-enhancible and EDTA-inhibitable phenomena in TSP-U937 cell-binding assay are due to the formation and solubilization of the precipitate. The observations that extra Ca2+ produced insoluble precipitates in the medium that were solubilized by EDTA, and that EDTA inhibits the increase of binding contributed by extra Ca2' suggested that the effects of extra Ca2' and EDTA on binding of TSP to U937 cells might be due to the formation and solubilization of the precipitate. To confirm this, the suspension binding assay was performed in CF-HBSS medium, which can hold up to 6 mM extra Ca2+ without precipitation. If the binding of TSP to U937 cell is sensitive to Ca2+, then a dramatic difference would be expected when I mM extra Ca2+ is added. Instead, there was no appreciable difference with or without I mM extra Ca2+ (Fig. 1 B) (Fig. 3  A) . Indeed, heparin increased the binding nearly threefold more when added in combination with 2 mM extra Ca2 . When this assay was performed in CF-HBSS, 2 mM extra Ca2+ did not increase the binding or reverse the inhibitory effect of heparin (Fig. 3 B) (Fig. 4 A) . If this binding was considered as "nonspecific," and the binding in the presence of extra Ca2' as "total," saturable "specific" binding curve was obtained ( Fig. 4 A, bottom, dashed line) . The binding data were analyzed using the Ligand program of Munson and Rodbard (27) for nonlinear curve fitting, as was done in reference 4. The analysis (Fig. 4 B) When '25I-TSP was incubated in RPMI/BSA without cells but with 1 mM extra Ca2" and centrifuged in the absence of silicone oil, > 65% of radioactivity was recovered in pellets indicating that TSP binds to the precipitate. The binding was competed by excess unlabeled TSP (Fig. 4 C, closed circles) . (28) (Fig.  4 C) and two apatite-binding proteins, hemoglobin and ovalbumin (29) (not shown), did not compete at concentrations up to 1 mg/ml; FN at this concentration competed minimally (Fig. 4 C) . Little radioactivity was recovered in the tips of microfuge tubes in the absence ofextra Ca2+ or when incubated in CF-HBSS in the presence of 2 mM extra Ca2+ (not shown).
Centrifugation of 251I-TSP and the precipitate through silicone oil in the absence of cells yielded inconsistent results.
Discussion
We found that addition of extra Ca2+ to RPMI medium resulted in a precipitate. The enhancement of TSP binding to U937 cells by extra Ca2' and the inhibition of that enhancement by EDTA, as had been previously reported (4, 5) I).
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The residual binding of TSP to U937 cells in the absence of calcium precipitate was unsaturable at TSP concentrations up to 300 ,g/ml2 and was not affected by heparin or EDTA. Since it has been reported that U937 cells and human monocytes express chondroitin sulfate but not heparan sulfate proteoglycan (30, 31) , these data support the hypothesis that cell surface heparan sulfate proteoglycan is an important mediator of TSP binding to cells (15) (16) (17) (18) . It was reported recently that U937 cells adhered to TSP coated substrates (32) . This adhesion was inhibited by RGD-containing peptide and dependent on the presence of Ca2+ in the TSP coating buffer. If TSP was coated in the presence of EGTA, it did not support U937 cell adhesion. In contrast, our TSP, precoated on tissue culture dishes (Falcon 3047; Becton Dickinson Labware, Lincoln Park, NJ) at a concentration of 20 ,g/ml, did not promote adhesion of U937 cells, whereas FN and fibrinogen supported adhesion when coated at concentrations as low as 0.02 ,ug/ml (not shown).
The binding of TSP to the mixture of precipitate and cells was saturable. The major class of binding site had a Kd very close to that previously reported (4). Our calculated maximum binding was fourfold higher than reported. This discrepancy could be explained by a difference in our experiment procedure. We dialyzed TSP into medium before it was added to the assay system. Because the RPMI medium was not diluted, more precipitate might have been produced when 1 mM Ca2+ was added. Thus more TSP would be in the bound fraction. Since the binding of TSP to the precipitate in the absence of silicone oil and cells had similar Kds, it appears that TSP mainly interacted with the precipitate rather than with cells.
The precipitates produced when extra Ca2" is added to the media are probably calcium phosphate as evidenced by the following pilot experiments. When 45CaC12 solution was added to media, radioactivity was found in the precipitate, and EDTA solubilized both precipitate and the radioactivity. Furthermore, calcium phosphate precipitates produced by addition of Ca2" to PBS or commercial hydroxyapatite (Sigma Chemical Co., St. Louis, MO) produced similar phenomena in TSP-MG63 monolayer-binding assay. TSP, FN, and VN bound to the precipitates produced by addition of Ca2" to culture media or PBS, as well as to commercial apatite, consistent with the fact that apatite binds many kinds of proteins (28) . Immunostaining of MG63 monolayer with TSP antisera, after incubation with TSP in the presence of extra Ca2+, revealed large fluorescent spots that corresponded to amorphous precipitates seen by phase microscopy. These spots were not seen in the absence of extra Ca2+. Instead, staining of MG63 cells looked like the staining of Chinese hamster ovary cells reported in reference 17. This result suggests that TSP may be absorbed to the insoluble precipitates which then bind to the cell surfaces. Although the binding of TSP to MG63 monolayers was increased in the presence ofextra Ca2", the degradation ofTSP by the cells was decreased (< 60% ofcontrol, not shown), supporting the notion that the increased binding was not receptor-mediated, at least not via the receptor that mediates TSP degradation. The turbidity increase in culture media is dependent on pH as well as on calcium concentration. There is a greater turbidity increase in the medium at higher pH than at lower pH. Although the pH is adjusted to 7.4 when the culture media are prepared, it gradually increases during storage (between 1 and 3 mo in our experiments) or after exposure to the air, and finally reaches a stable point between 8.3 and 8.4. Addition of 15 mM Hepes blunts but does not completely block this pH shift. Incubating the high pH (> 8) media in cell culture incubator that contains 5% CO2 will lower the pH to physiological range, but only after several hours. We observed similar effects in TSP-MG63 cell-binding assays done in open air for 2 h (Fig. 3 A,  40C ) or in cell culture incubator containing 5% CO2 for I h (Fig. 3 C, 37QC ). Since most extracellular protein-cell binding assays are performed in cell culture medium and since divalent cations regulate binding of many kinds of ligands to their cell surface receptors, our studies emphasize the care that should be taken when one adds extra divalent cation to the culture media in cell-binding assays to avoid the formation of precipitate.
Binding of TSP to insoluble calcium may have physiological and pathological relevance in vivo, since TSP has been found to be deposited in calcified tissues such as bone (33) and atherosclerotic plaque (34) . It was reported that TSP in activated platelet supernatant solution is adsorbed quantitatively to barium citrate precipitate while other proteins in the supernatant solution were barely adsorbed (35) . Although evidence suggests that y-carboxyglutamic acid residues are involved in adsorption to barium citrate precipitate (36) , TSP contains no detectable y-carboxyglutamic acid (35) . TSP is a Ca2+-binding protein (37) . It has a number of potential Ca2+-binding sites in its type 3 homology sequences (38) . In addition, its second type 2 homology sequence probably contains a /l-hydroxyasparagine (39) , which has been implicated in Ca2" binding to a proteolytically derived epidermal growth factor (EGF)-like domain of Factor X (40). It is not known whether or not the Ca2+-binding sites are involved in the binding of TSP to the calcium precipitate, since the correlation between Ca2' binding and apatite binding has not been established.
